Sifrol®

DRUG3 trials

Sponsors

Boehringer Ingelheim

Conditions

HealthyParkinson Disease

Phase 1

A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole

Active, not recruitingNCT07727785

Boehringer IngelheimHealthy

Start: 2026-08-05End: 2026-09-28Updated: 2026-09-15

Unknown Phase

Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease

CompletedNCT02231255

Boehringer IngelheimParkinson Disease

Start: 2002-02-28Updated: 2014-09-17

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

CompletedNCT02231294

Boehringer IngelheimParkinson Disease

Start: 2000-07-31Updated: 2014-09-04